Genetic testing panel
This article was originally published in The Gray Sheet
Executive Summary
HHS Secretary's advisory committee on genetic testing (SACGT) will hold its first meeting June 30 on the National Institutes of Health campus in Bethesda. Edward McCabe, MD, an NIH-funded pediatrician at the University of California at Los Angeles, chairs the 13-member panel. Other members include Centers for Disease Control and Prevention's Clinical Laboratory Improvement Advisory Committee member Patricia Charache, MD, and Joann Boughman, PhD, a member of FDA's Medical Devices Advisory Committee. Panelists will report to HHS Assistant Secretary David Satcher, who will give the group its charge June 30. SACGT will meet twice yearly and have an estimated annual budget of $130,000. HHS Secretary Donna Shalala convened the group to advise on "development, validation and regulation of genetic tests," following recommendations by two NIH panels
You may also be interested in...
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.
Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says
Updated draft guidance on promotion of biologic reference products, biosimilars and interchangeable biosimilars offers another indication of the US’s push to do away with the interchangeability designation.